Your browser is no longer supported. Please, upgrade your browser.
Settings
HZNP Horizon Pharma Public Limited Company daily Stock Chart
HZNP [NASD]
Horizon Pharma Public Limited Company
Index- P/E- EPS (ttm)-2.29 Insider Own0.80% Shs Outstand166.81M Perf Week-0.05%
Market Cap3.20B Forward P/E10.23 EPS next Y1.88 Insider Trans-8.67% Shs Float165.14M Perf Month-4.67%
Income-375.60M PEG- EPS next Q0.50 Inst Own92.80% Short Float6.22% Perf Quarter12.87%
Sales1.07B P/S2.99 EPS this Y-186.70% Inst Trans1.91% Short Ratio7.84 Perf Half Y34.43%
Book/sh5.20 P/B3.69 EPS next Y17.02% ROA-7.30% Target Price23.18 Perf Year55.93%
Cash/sh4.26 P/C4.51 EPS next 5Y18.90% ROE-32.40% 52W Range11.17 - 21.25 Perf YTD31.58%
Dividend- P/FCF15.35 EPS past 5Y-5.70% ROI-12.60% 52W High-9.60% Beta1.39
Dividend %- Quick Ratio1.60 Sales past 5Y123.70% Gross Margin54.00% 52W Low71.98% ATR0.58
Employees980 Current Ratio1.70 Sales Q/Q4.60% Oper. Margin-21.20% RSI (14)43.71 Volatility2.73% 2.98%
OptionableYes Debt/Eq2.19 EPS Q/Q84.60% Profit Margin-28.00% Rel Volume0.75 Prev Close18.82
ShortableYes LT Debt/Eq2.19 EarningsAug 08 BMO Payout- Avg Volume1.31M Price19.21
Recom2.10 SMA20-4.76% SMA50-0.52% SMA20018.95% Volume1,070,460 Change2.07%
Jun-27-18Downgrade Citigroup Buy → Neutral
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Nov-28-16Upgrade Citigroup Neutral → Buy
Nov-08-16Reiterated Mizuho Buy $29 → $30
Oct-31-16Reiterated Mizuho Buy $33 → $29
Sep-13-16Reiterated Mizuho Buy $30 → $33
Jul-11-16Upgrade Morgan Stanley Underweight → Equal-Weight $24
Jun-06-16Initiated Goldman Buy $24
May-10-16Reiterated Mizuho Buy $25 → $24
May-03-16Reiterated Mizuho Buy $34 → $25
Jan-19-16Resumed Jefferies Buy $31
Jan-06-16Resumed Citigroup Neutral
Dec-17-15Initiated Goldman Buy
Sep-07-18 09:30AM  Horizon Pharma (HZNP) Down 1.9% Since Last Earnings Report: Can It Rebound? Zacks
Sep-05-18 05:34PM  Horizon Pharma Completes Enrollment in Eye Disease Study Zacks
Sep-04-18 08:00AM  Horizon Pharma plc to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference Business Wire
07:00AM  Horizon Pharma plc Completes Enrollment of Confirmatory Phase 3 Trial of Teprotumumab Ahead of Schedule Business Wire
Aug-27-18 05:44AM  Edited Transcript of HZNP earnings conference call or presentation 8-Aug-18 12:00pm GMT Thomson Reuters StreetEvents
Aug-24-18 08:35AM  These 3 Value Stocks Are Absurdly Cheap Right Now Motley Fool
Aug-22-18 06:22AM  Horizon Pharma (HZNP) Boasts Robust Pipeline Amid Competition Zacks
Aug-21-18 08:10AM  Investor Expectations to Drive Momentum within Materialise NV, Southern First Bancshares, Ensco plc, Corbus Pharmaceuticals, TCP Capital, and Horizon Pharma Public Discovering Underlying Factors of Influence GlobeNewswire
Aug-09-18 09:17AM  Horizon Pharma (HZNP) Q2 Earnings & Sales Beat, Shares Rise Zacks
Aug-08-18 03:51PM  Here's Why Horizon Pharma PLC Rose by Double Digits Today Motley Fool +10.79%
08:50AM  Horizon Pharma (HZNP) Tops Q2 Earnings and Revenue Estimates Zacks
07:45AM  Horizon Pharma: 2Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Record Quarterly Net Sales for Orphan and Rheumatology Segment; Increases Full-Year 2018 Adjusted EBITDA Guidance; Implements New Company Operating Structure to Enhance Focus on Rare Diseases Business Wire
Aug-06-18 11:21AM  Is a Beat in Store for Horizon Pharma (HZNP) in Q2 Earnings? Zacks
Jul-25-18 09:00AM  PEOPLE and Great Place to Work® Name Horizon Pharma plc to 2018 50 Companies That Care List Business Wire
Jul-23-18 03:05PM  7 Healthcare Stocks That Are Coming to Life InvestorPlace
Jul-19-18 07:50AM  Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities ACCESSWIRE
Jul-16-18 08:30AM  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid Business Wire
Jul-10-18 09:30AM  HZNP vs. LGND: Which Stock Is the Better Value Option? Zacks
Jul-09-18 08:30AM  Horizon Pharma plc to Release Second-Quarter 2018 Financial Results and Host Webcast on August 8, 2018 Business Wire
Jul-03-18 03:08PM  10 Underappreciated Biotech Stocks to Buy Kiplinger
Jun-18-18 07:05AM  Free Research Reports on Ironwood Pharma and Three More Generic Drugs Stocks ACCESSWIRE
Jun-15-18 07:00AM  Watertown biotech Selecta touts improved gout drug data in trial American City Business Journals
05:45AM  Horizon Pharma plc Presents Data at EULAR 2018 Advancing the Understanding and Management of Uncontrolled Gout GlobeNewswire
Jun-14-18 04:50AM  Epidemiologic Study Findings Show 27 Percent Increase in Emergency Department Visits for Gout in the United States Over the Past Decade GlobeNewswire
Jun-11-18 08:20AM  Today's Research Reports on Trending Tickers: Teva Pharmaceutical and Horizon Pharma ACCESSWIRE
Jun-08-18 10:13AM  Why Is Horizon Pharma (HZNP) Up 18.3% Since Its Last Earnings Report? Zacks +5.63%
Jun-07-18 07:40AM  Report: Exploring Fundamental Drivers Behind Horizon Pharma Public, Lululemon Athletica, Nordic American Tankers, UBS Group AG, 21Vianet Group, and Sandstorm Gold New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-06-18 10:02AM  What You Must Know About Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Financial Strength Simply Wall St.
Jun-04-18 08:00AM  Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention GlobeNewswire
Jun-01-18 05:08PM  Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up Zacks
May-30-18 08:00AM  Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
May-29-18 08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and The Medicines Company ACCESSWIRE
May-22-18 06:13PM  Edited Transcript of HZNP earnings conference call or presentation 9-May-18 12:00pm GMT Thomson Reuters StreetEvents
10:15AM  Horizon Pharma plc Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE GlobeNewswire
09:00AM  Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with Uncontrolled Gout GlobeNewswire
May-14-18 02:54PM  Phase two of clinical gout trial begins at UAB American City Business Journals +5.12%
May-11-18 07:00AM  Free Daily Technical Summary Reports on Horizon Pharma and Three More Generic Drugs Stocks ACCESSWIRE
May-10-18 10:33AM  Horizon Pharma (HZNP) Q1 Earnings & Sales Miss, Shares Fall Zacks
08:30AM  Today's Research Reports on Trending Tickers: Horizon Pharma and Ironwood Pharmaceuticals ACCESSWIRE
May-09-18 08:00AM  Horizon Pharma (HZNP) Q1 Loss Wider, Revenues Miss Zacks -5.60%
07:35AM  Horizon Pharma: 1Q Earnings Snapshot Associated Press
07:00AM  Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases GlobeNewswire
May-08-18 12:51PM  What Are Analysts Saying About Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Earnings Trajectory? Simply Wall St.
08:00AM  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid GlobeNewswire
May-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-03-18 08:39AM  Zacks.com highlights: Western Digital, Daqo New Energy, Horizon Pharma Public and American Axle & Manufacturing Holdings Zacks
08:00AM  Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomens Association Rising Star GlobeNewswire
May-02-18 08:16AM  4 Low P/CF Stocks Ready to Add Value to Your Investment Zacks
May-01-18 08:00AM  Horizon Pharma plc to Participate in the UBS Global Healthcare Conference GlobeNewswire +6.95%
Apr-20-18 08:39AM  Eleven Biotherapeutics (EBIO) in Focus: Stock Moves 8.7% Higher Zacks
Apr-18-18 06:33AM  Zacks.com highlights: Western Digital, ArcelorMittal, Arrow Electronics and Horizon Pharma Public Zacks
Apr-17-18 09:38AM  Pick These 4 Low P/CF Stocks & Sail Through a Volatile Market Zacks
Apr-12-18 04:30PM  Horizon Pharma plc Named No. 1 Biopharma Company to Work for by Great Place to Work® and FORTUNE GlobeNewswire
Apr-11-18 08:20AM  New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-09-18 08:00AM  Horizon Pharma plc to Release First-Quarter 2018 Financial Results and Host Webcast on May 9, 2018 GlobeNewswire
Apr-06-18 09:27AM  4 Drug/Biotech Stocks to Buy Ahead of World Health Day Zacks
05:00AM  When These New Pharma Bros Show Up, Drug Prices Tend to Go Monumentally Higher Bloomberg
Apr-05-18 10:37AM  Conatus' Emricasan Fails in Phase II Study, Shares Sink Zacks
Apr-04-18 08:00AM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Apr-02-18 09:56AM  Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease Zacks
05:56AM  Horizon Pharma (HZNP) Down 3.9% Since Earnings Report: Can It Rebound? Zacks
Mar-31-18 07:00AM  3 Top Value Stocks to Buy Right Now Motley Fool
Mar-29-18 05:31PM  Edited Transcript of HZNP earnings conference call or presentation 28-Feb-18 1:00pm GMT Thomson Reuters StreetEvents
07:45AM  Is a Recession in the Cards? 4 Safe Bets for Your Portfolio Zacks
Mar-27-18 10:08AM  Protagonist Therapeutics Stalls Ulcerative Colitis Study Zacks
Mar-26-18 10:20AM  Pfizer's Chantix Fails in Phase IV Study in Young Smokers Zacks
09:40AM  Clovis Gets Positive CHMP Opinion for Ovarian Cancer Drug Zacks
Mar-21-18 10:55AM  Seattle Genetics' Adcetris Gets FDA Nod for Label Expansion Zacks
08:47AM  Ignore Trump's Pricing Rhetoric With These 5 Biotech Picks Zacks
Mar-20-18 11:49AM  Heron's Pain Candidate Meets Endpoint in Pivotal Studies Zacks
11:43AM  Arena's (ARNA) Etrasimod Meets Phase II Colitis Study Goal Zacks
Mar-19-18 10:18AM  Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up Zacks
Mar-15-18 10:00AM  Is Horizon Pharma Public (HZNP) a Great Stock for Value Investors Right Now? Zacks
08:09AM  Physicians And Patients Finally Avoiding Horizon's Expensive, Low-Value Pain Drugs Duexis And Vimovo Forbes
Mar-13-18 04:32PM  Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts Benzinga
11:20AM  Sarepta to Seek Rapid Approval for Second DMD Drug, Stock Up Zacks
07:30AM  Investor Expectations to Drive Momentum within Methanex, YPF Sociedad Anonima, Adaptimmune Therapeutics, Horizon Pharma, Changyou, and China Yuchai International Discovering Underlying Factors of Influence GlobeNewswire
Mar-12-18 09:15AM  Zacks.com highlights: TheStreet, Barclays, Horizon Pharma, Regions Financial and TechTarget Zacks
Mar-09-18 06:32AM  5 Cheap Breakout Stocks for Explosive Returns Zacks
Mar-07-18 07:10AM  Wired News Zynerba Pharma Held Positive Discussion Meeting with FDA for its ZYN002 Development Strategy ACCESSWIRE
Mar-06-18 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Mar-02-18 10:01AM  Horizon Pharma (HZNP) Tops Q4 Earnings, Provides 2018 View Zacks
Feb-28-18 08:45AM  Horizon Pharma reports 4Q loss Associated Press
08:43AM  Are Horizon Pharma Public Limited Companys (NASDAQ:HZNP) Interest Costs Too High? Simply Wall St.
08:25AM  Horizon Pharma (HZNP) Tops Q4 Earnings, Revenues Beat Zacks
07:00AM  Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2017 Results GlobeNewswire
Feb-27-18 06:00PM  Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI® (glycerol phenylbutyrate) Oral Liquid to Expand Age Range to Include Newborns GlobeNewswire
Feb-26-18 08:00AM  Horizon Pharma Gift Establishes First Clinical Team Endowment at Childrens National Rare Disease Institute GlobeNewswire
07:00AM  Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-23-18 09:26AM  Is a Beat in Store for Horizon Pharma (HZNP) in Q4 Earnings? Zacks
Feb-22-18 09:00AM  Horizon Pharma plc Announces Release of the First RAREis Song in Partnership with Sing Me a Story Foundation and Global Genes GlobeNewswire
Feb-15-18 02:12AM  [$$] Irish drugmaker Horizon Pharma raises painkiller price to $3,000 in US Financial Times
Feb-06-18 04:05PM  Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-30-18 08:30AM  Horizon Pharma plc Announces the Launch of Cystinosis United to Educate, Inspire and Connect the Cystinosis Community GlobeNewswire
Jan-29-18 08:00AM  Horizon Pharma plc to Release Fourth-Quarter and Full-Year 2017 Financial Results and Host Webcast on Feb. 28, 2018 GlobeNewswire
Jan-15-18 07:30AM  Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC CNW Group
Jan-09-18 03:57PM  U.S. pharma executives expect deals to pick up after tax overhaul Reuters
01:24PM  U.S. pharma executives expect deals to pick up after tax overhaul Reuters
08:07AM  See what the IHS Markit Score report has to say about Horizon Pharma PLC. Markit
Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. The company's marketed medicine portfolio consists of RAVICTI for the treatment of urea cycle disorders; PROCYSBI to treat nephropathic cystinosis; ACTIMMUNE for the treatment of chronic granulomatous disease and malignant osteopetrosis; BUPHENYL to treat urea cycle disorders; and QUINSAIR for the treatment of chronic pulmonary infections due to pseudomonas aeruginosa in cystic fibrosis patients. Its products also include KRYSTEXXA to treat chronic refractory gout; RAYOS/LODOTRA for the treatment of rheumatoid arthritis, polymyalgia rheumatic, systemic lupus erythematosus, and various other indications; PENNSAID 2% to treat pain of osteoarthritis of the knees; DUEXIS for the treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis; VIMOVO to treat signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; and MIGERGOT for the treatment of vascular headache. The company has collaboration agreement with Fox Chase Cancer Center to evaluate ACTIMMUNE in combination with PD-1/PD-L1 inhibitors in various forms of cancer; Alliance for Lupus Research to evaluate RAYOS/LODOTRA on the fatigue experienced by systemic lupus erythematosus patients; and Syneos Health, Inc. in connection with its Phase III confirmatory trial to evaluate teprotumumab for the treatment of thyroid eye disease. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOAug 16Sale20.639,904204,36128,767Aug 20 04:29 PM
Beeler Brian KEVP, General CounselJun 08Sale17.5815,433271,24979,530Jun 12 05:00 PM
Walbert Timothy PChairman, President and CEOJun 01Option Exercise10.4383,353869,372629,423Jun 05 04:13 PM
Walbert Timothy PChairman, President and CEOJun 01Sale16.1783,3531,348,218546,070Jun 05 04:13 PM
Beeler Brian KEVP, General CounselMay 25Option Exercise2.4048,000115,200110,524May 30 04:49 PM
Beeler Brian KEVP, General CounselMay 25Sale16.1117,931288,86892,593May 30 04:49 PM
Walbert Timothy PChairman, President and CEOJan 02Option Exercise0.0049,5000497,701Jan 03 06:25 PM